Health commissioner: Marijuana program needs more doctors to participate
Rutgers New Jersey Medical School first year student Daniel Oh asked Elnahal if there was any monitoring to make sure mistakes aren’t repeated.
“The side effect profile, in particular the risk for dependence, addiction, overdose, death — all of those are much lower and nonexistent for marijuana versus opioids. The other thing is we’re not necessarily recommending it as a first-line therapy, we’re just allowing you now to recommend it as a first-line therapy. It’s still a clinical judgement,” Elnahal replied.